Treatment of two rare diseases, metachromatic leukodystrophy and Wiskott-Aldrich syndrome (WAS)
A study published in the online edition of the American scientific journal Science has revealed a new model of gene therapy to treat or prevent rare or serious hereditary diseases in children, without the risk of causing cancer.
The treatment consisted of extracting stem cells from the patients' own bone marrow, manipulating them in the laboratory by adding an HIV virus vector to correct the genetic defect causing their diseases, and finally injecting them back into the patients' bodies.
These trials have treated six children at the San Rafael Institute in Milan for two rare diseases, metachromatic leukodystrophy and Wiskott-Aldrich syndrome (WAS). All six children have been cured thanks to the new gene therapy. Two years after treatment, the children are leading normal lives and are able to attend school.
Biomedicine Immunogenetics
At Biosalud, we recommend immunogenetic biomedicine for treating diseases from their genetic origin. In this century, immunogenetic medicine plays a very important role in health.
For the treatment of diseases, Immunogenetic Biomedicine is applied in two fundamental areas: preventive (cancers, degenerative or autoimmune diseases, angina pectoris and heart attacks, etc.) and therapeutic (degenerative and autoimmune diseases, musculoskeletal system, nervous system, skin, digestive system, cardiovascular system, metabolic, psychiatric, ocular, allergies, etc.).
